Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

House Republicans released a budget plan Wednesday that sets the stage for advancing many of President Donald Trump's top ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

With physicians' and patients' awareness expected to increase, sales of obesity medications are estimated to reach $173.5 billion in the seven major markets (7MM - US, France, Germany, Italy ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and ...